Sina Gallo, RD, MSc; Kathryn Comeau, RD, MSc; Catherine Vanstone, RN, MSc; et al.
free access
has audio
JAMA. 2013;309(17):1785-1792. doi:10.1001/jama.2013.3404
Gallo and coauthors conducted a randomized trial among 132 one-month-old healthy, term, breastfed infants with 11 months of follow-up to investigate the efficacy of different dosages of cholecalciferol in supporting 25-hydroxyvitamin D concentrations in infants. In an editorial, Abrams discusses targeting dietary vitamin D intakes in healthy infants.
-
Audio Author Interview:
Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants: A Randomized Trial
Simon R. M. Dobson, MD; Shelly McNeil, MD; Marc Dionne, MD; et al.
free access
has multimedia
has audio
JAMA. 2013;309(17):1793-1802. doi:10.1001/jama.2013.1625
In a multicenter, age-stratified study of 830 healthy females, Dobson and coauthors determine whether mean antibody levels to human papillomavirus (HPV)–16 and HPV-18 among girls receiving 2 doses was noninferior to young women receiving 3 doses in an effort to protect against cervical cancer.
-
Audio Author Interview:
Immunogenicity of 2 Doses of Human Papillomavirus Vaccine in Younger Adolescents Versus 3 Doses in Young Women: A Randomized Clinical Trial
-
Editorial
HPV Vaccination: Too Soon for 2 Doses?
Jessica A. Kahn, MD, MPH; David I. Bernstein, MD, MA
JAMA
Elizabeth D. Lowenthal, MD, MSCE; Jonas H. Ellenberg, PhD; Edwin Machine, MPH; et al.
free access
JAMA. 2013;309(17):1803-1809. doi:10.1001/jama.2013.3710
Lowenthal and coauthors report on the association between efavirenz-based vs nevirapine-based antiretroviral regimens and virological failure in children infected with human immunodeficiency virus.
Fredrik Serenius, MD, PhD; Karin Källén, PhD; Mats Blennow, MD, PhD; et al.
free access
JAMA. 2013;309(17):1810-1820. doi:10.1001/jama.2013.3786
Serenius and colleagues study neurodevelopmental outcome in extremely preterm children at 2.5 years (corrected age) in 491 survivors compared with control participants in a population-based prospective cohort in Sweden.
Elisha M. Wachman, MD; Marie J. Hayes, PhD; Mark S. Brown, MD, MSPH; et al.
free access
JAMA. 2013;309(17):1821-1827. doi:10.1001/jama.2013.3411
In a multicenter cohort study conducted in the northeastern United States, Wachman and coauthors determined if certain single-nucleotide polymorphisms (SNPs) are associated with length of hospital stay and need for treatment in infants with neonatal abstinence syndrome.